Distribution and drug prices, An ever shorter cover between Europe and the US

The debate on drug reimportation from Canada trained the spot, in the Unites States and therefore in the rest of the world, on a significant, albeit often unspoken issue. Facing the fact that the US is the largest market in the world for consumption of pharmaceutical drugs, the American patient pays a significantly higher price for his drugs than his European counterpart. The European per capita pharmaceutics costs is 60 per cent below the American one:1 inevitably, this difference discourages the development of innovative drugs, as confirmed by the flight to America of European drug firms that still have R&D efforts.

Click here to read the full publication →